Navigation Links
Lo studio EXAMINE della Takeda sulla sicurezza cardiovascolare di alogliptin in aggiunta alla terapia standard ha soddisfatto l'endpoint primario di non inferiorità rispetto al placebo dimostrando che non si verifica nessun incremento del rischio ca
Date:9/17/2013

da termini previsionali quali "potere," "credere," "sarà," "aspettarsi," "proiettare," "stimare," "dovere," "anticipare," "pianificare," "ipotizzare," "continuare," "ricercare," "pro forma," "potenziale," "obiettivo," "previsioni," "direzione," "prospettive" o "avere intenzione" o locuzioni e termini simili comprese le forme negative di quanto sopra. Le dichiarazioni previsionali si basano su stime e ipotesi della direzione aziendale che si ritiene siano ragionevoli, sebbene siano per loro natura incerte e di difficile previsione. SI mettono in guardia gli investitori dal non fare eccessivamente affidamento su tali dichiarazioni previsionali.

Le dichiarazioni previsionali implicano rischi e incertezze che potrebbero determinare differenze sostanziali nei risultati effettivi o nella realtà dei fatti rispetto a quanto espresso o implicito in tali dichiarazioni previsionali. Alcuni di questi rischi e incertezze comprendono, ma non si limitano a ciò, (1) le condizioni economiche nelle quali opera Takeda, comprese le condizioni generale economiche in Giappone, negli Stati Uniti e nel mondo; (2) la pressione e gli sviluppi della concorrenza; (3) le norme e i regolamenti applicabili; (4) il successo o l'insuccesso dei programmi di sviluppo dei prodotti; (5) le azioni delle autorità normative e la loro tempistica; (6) cambiamenti dei tassi di cambio; (7) richieste di risarcimento o preoccupazioni relative alla sicurezza o all'efficacia dei prodotti commercializzati o dei prodotti candidati in sviluppo; e (8) le attività mirate all'integrazione con le società acquisite.

Le dichiarazioni previsionali riportate nel presente comunicato stampa sono valide esclusivamente alla data del presente comunicato e Takeda non assume alcun obbligo in merito alla loro revisione o aggiornamento in modo che riflettano nuove informazioni, eventi o circostanze future intervenute successivamente alla data delle dichiarazioni previsionali.
'/>"/>

SOURCE Takeda Pharmaceutical Company Limited
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Anthony Creed Joins DDSTUDIO As GM, Experience Design
2. Daiichi Sankyo ha completato larruolamento dei pazienti per lo studio Hokusai-VTE su Edoxaban, il più ampio trial clinico di fase 3 per il trattamento delle tromboembolie venose ricorrenti
3. Lo studio pubblicato su European Radiology esalta ulteriormente lutilizzo della tomosintesi al seno di Hologic nellambito dello screening del cancro con utilizzo della doppia lettura
4. I benefici della tecnologia Hologic per lutilizzo della Tomosintesi in vengono corroborati dalla pubblicazione di uno studio italiano
5. Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2
6. River City Laser Tattoo Removal Studio Offers Grand Opening Discounts on Treatments Using the Astanza Revolution Laser
7. New post-hoc analyses examined Neupro® effects on pain, depressed mood, apathy and fatigue in patients with Parkinsons disease
8. New 2012 Cold Chain Report Examines the Extent of Temperature Excursions During the Handling of Temperature-Sensitive Pharmaceutical Shipments
9. Study Examines Smart Pharma Strategies for Effective Messaging around New Products and the Medical Conditions they Treat
10. TeamHealth White Paper Examines Telemedicine Risks, Risk Management Strategies
11. The Food Journal Examines Dietary Supplements
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... 23, 2015  Today the U.S. Food and Drug Administration ... prevention of serogroup B meningococcal disease in ... Trumenba®, which received FDA approval in October, represent a ... "I have heard over and over ...
(Date:1/23/2015)... 2015  The Partnership to Fight Chronic Disease (PFCD) released a public ... and a new study analyzing the impact of increased cost sharing ... coalition working to educate policy makers and the public on the ... focused on how the Iowa healthcare exchange ...
(Date:1/23/2015)... 23, 2015 More than a third of reproductive-aged women ... with private insurance, filled a prescription for an opioid pain ... this week,s Morbidity and Mortality Weekly Report (MMWR). ... treat moderate to severe pain.  They are also found in ...
Breaking Medicine Technology:The National Meningitis Association (NMA) Applauds FDA Approval of Second Vaccine To Protect Against Serogroup B Meningococcal Disease 2New research shows Iowa health exchange would benefit from improvements 2New research shows Iowa health exchange would benefit from improvements 3Opioid painkillers widely prescribed among reproductive age women 2Opioid painkillers widely prescribed among reproductive age women 3
... FRANKLIN LAKES, N.J., Nov. 3, 2010 BD (Becton, Dickinson ... medical technology company, today reported quarterly revenues of $1.873 billion ... an increase of 1.0 percent from the prior-year period, or ... For the full fiscal year ended September 30, 2010, BD ...
... EATONTOWN, N.J., Nov. 3, 2010 Osteotech, Inc. (Nasdaq: ... field of biologic products for regenerative healing, announced today ... has been selected to receive the Research and Development ... Award in the medical category.  Osteotech was chosen from ...
Cached Medicine Technology:BD Announces Results for 2010 Fourth Fiscal Quarter and Full Year 2BD Announces Results for 2010 Fourth Fiscal Quarter and Full Year 3BD Announces Results for 2010 Fourth Fiscal Quarter and Full Year 4BD Announces Results for 2010 Fourth Fiscal Quarter and Full Year 5BD Announces Results for 2010 Fourth Fiscal Quarter and Full Year 6BD Announces Results for 2010 Fourth Fiscal Quarter and Full Year 7BD Announces Results for 2010 Fourth Fiscal Quarter and Full Year 8BD Announces Results for 2010 Fourth Fiscal Quarter and Full Year 9BD Announces Results for 2010 Fourth Fiscal Quarter and Full Year 10BD Announces Results for 2010 Fourth Fiscal Quarter and Full Year 11BD Announces Results for 2010 Fourth Fiscal Quarter and Full Year 12BD Announces Results for 2010 Fourth Fiscal Quarter and Full Year 13BD Announces Results for 2010 Fourth Fiscal Quarter and Full Year 14BD Announces Results for 2010 Fourth Fiscal Quarter and Full Year 15BD Announces Results for 2010 Fourth Fiscal Quarter and Full Year 16BD Announces Results for 2010 Fourth Fiscal Quarter and Full Year 17Osteotech's Plexur M® Technology Wins Thomas Alva Edison Patent Award from the New Jersey Research and Development Council 2Osteotech's Plexur M® Technology Wins Thomas Alva Edison Patent Award from the New Jersey Research and Development Council 3
(Date:1/22/2015)... (PRWEB) January 22, 2015 Joan Lunden, ... keynote speaker at the upcoming 32nd Annual Miami ... Physicians’ Education Resource®, LLC (PER®) , shares that ... have gone undetected if she had not followed up ...
(Date:1/22/2015)... Recently, Weddingshe.com has added many trendy Champagne wedding ... revenues in the past three years. Today, the business announces ... According to the sales manager of the company, this is ... 2015. This point can be reflected on the discounted wedding ...
(Date:1/22/2015)... Payday lending practices in four southern states ... distress to the states that permit them, according to ... on Race and Wealth. , While they generate hundreds ... at the same time substantially depress economic activity, according ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 JJsHouse.com is a ... dresses. Today, the business announces its latest collection of ... , “The most important issue is the wedding dress on ... thing in a woman’s life. Every bride wants to find ...
(Date:1/22/2015)... Step into a macabre world where plants hold ... Wicked Plants, the Museum’s latest featured exhibition, opens Saturday, ... and diabolical plants inside of a dilapidated, Victorian home. ... physical and neurological processes between botanicals and the human ...
Breaking Medicine News(10 mins):Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 2Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 3Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 4Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 5Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 6Health News:Weddingshe Announces A Special Offer On Its Popular Glamorous Wedding Dresses 2Health News:Howard University Spotlights the Economic Impact of Payday Lending in Southern States 2Health News:Find The Most Suitable Wedding Dress At JJsHouse.com 2Health News:Wicked Plants are taking over the Science Museum of Virginia 2
... could bring new treatment options for patients, researchers ... Surgery patients may one day find nicotine patches ... pad, researchers say. , Nicotine patches and the ... surgery, according to two studies presented at the ...
... Texas, 181,legislators are being honored with the Texas ... on behalf of health care,during the 80th Session ... the award in 1997 to honor state legislators ... issues important,to hospitals and health systems. Recipients ...
... Arthur H. Rubenstein,MBBCh, executive vice president for the health ... Dunlop professor of medicine at the University,of Pennsylvania, has ... the,Association of Academic Health Centers., Dr. Rubenstein served ... New,York before assuming his current position at the University ...
... stomach risks, study notes , , MONDAY, Oct. 15 ... their doctors that they take common over-the-counter painkillers, such ... new study has found. , "With nearly one out ... no wonder that adverse events are increasing yearly," said ...
... 15 /PRNewswire/ - Neuromed,Pharmaceuticals, a biopharmaceutical company developing ... has successfully reached an,agreement with the U.S. Food ... (SPA) process for the planned pivotal Phase 3,clinical ... of,chronic pain. A SPA is a procedure by ...
... Edwards Lifesciences,Corporation (NYSE: EW ), a global ... plans to announce its operating,results for the quarter ended ... 22, 2007 and will host a conference call at ... To participate in the conference call, dial (877) 407-8037 ...
Cached Medicine News:Health News:Nicotine, Chili Peppers Offer Post-Surgery Pain Relief 2Health News:Nicotine, Chili Peppers Offer Post-Surgery Pain Relief 3Health News:THA Honors Nine Legislators for Contributions to Health Care 2Health News:Association of Academic Health Centers Names University of Pennsylvania's Dr. Arthur H. Rubenstein Chairman of the Board of Directors 2Health News:Many Patients Don't Report Use of OTC Pain Drugs 2Health News:Many Patients Don't Report Use of OTC Pain Drugs 3Health News:Neuromed Concludes a Special Protocol Assessment (SPA) with FDA for a Pivotal Phase 3 Study on NMED-1077 2Health News:Neuromed Concludes a Special Protocol Assessment (SPA) with FDA for a Pivotal Phase 3 Study on NMED-1077 3Health News:Edwards Lifesciences to Host Earnings Conference Call on October 22, 2007 2
...
Digital Ultrasonic Diagnostic Imaging System...
...
Pefakit PiCT DxS Diluent for Determination of Total Heparin...
Medicine Products: